" "
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BD Launches Innovative Diabetes Pen Needle

Published: Thursday, March 27, 2014
Last Updated: Thursday, March 27, 2014
Bookmark and Share
BD Micro-Fine Ultra™ with Pentapoint 5-bevel technology helps to enhance patient comfort.

BD (Becton, Dickinson and Company) has announced the launch in the UK and Ireland of BD Micro-Fine Ultra™ with 5-bevel needle technology, clinically demonstrated to improve injection comfort for diabetes patients, and enhancing the injection advantages of the current BD Micro-Fine™+ Pen Needle.

A patient study found the five-bevel pen needles to be less painful, easier to insert and more comfortable, when compared with current three-bevel pen needles. This new Pentapoint™ 5-bevel technology is the next in a series of innovations to come from BD Medical - Diabetes Care, resulting in a BD Premium Pen Needle product line which will be called BD Micro-Fine Ultra™.

Studies suggest that as many as one-fifth to one-third of people with diabetes are hesitant or unwilling to give themselves insulin injections for reasons that include needle anxiety. Also, patients who reported injection-related pain or embarrassment intentionally skipped insulin injections more often.

The BD Micro-Fine Ultra™ Pen Needle with Pentapoint™ technology reduces skin penetration force by 23% on average, and is clinically demonstrated to reduce the pain of injection. This may help people with diabetes adhere to an insulin injection regimen and improve outcomes with greater comfort and ease of use.

The BD Micro-Fine Ultra™ with Pentapoint™ needle tip is specially designed with five-beveled edges to create a flatter, thinner surface to penetrate the skin with significantly greater ease, for a smoother and more comfortable injection experience, compared to previous generation three bevel needles. Pentapoint™ technology is available in 4mm pen needles.

Matthias Borst, VP / GM Europe, BD Medical - Diabetes Care, comments: “BD Diabetes Care has been a leader in diabetes injection devices for almost 90 years, and is committed to helping improve the injection experience for the millions of people living with diabetes, through ongoing patient education, the constant pursuit of innovation and improvement, and the development of high-quality products that make a difference. Building on the introduction of the BD Micro-Fine™+ 4mm Pen Needle in 2010, we are confident that our new Pentapoint™ technology will provide an even more comfortable injection experience, helping to minimize injection resistance, fear and anxiety in people with diabetes, enabling them more easily to adopt and adhere to the therapy regimens recommended to improve their diabetes care.”

The BD Micro-Fine Ultra™ 4mm Pen Needle is proven to be as effective as longer needles for patients of all body types, and provides equivalent glucose control by more effectively delivering the insulin dose to subcutaneous tissue (the layer of fat below the skin), the recommended site for insulin injections, and reducing the risk of injecting into muscle.

Intramuscular injection can accelerate insulin absorption and increase the risk of hypoglycemia (abnormally low blood sugar). Subcutaneous injection allows the insulin to be absorbed at an appropriate rate, resulting in better glycaemic control.

The BD Micro-Fine Ultra™ 4mm Pen Needle with Pentapoint technology has delivered a significant step forward in enhancing patient comfort and injection outcomes.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
‘Smelling’ Prostate Cancer
A research team from the University of Liverpool and the University of the West of England (UWE Bristol) has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures that men currently undergo eventually become a thing of the past.
Criminal Justice Alcohol Program Linked to Decreased Mortality
Institute has announced that in the criminal justice alcohol program deaths dropped by 4.2 percent over six years.
Charting Kidney Cancer Metabolism
Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.
Individuals' Medical Histories Predicted by their Noncoding Genomes
Researchers have found that analyzing mutations in regions of the genome that control genes can predict medical conditions such as hypertension, narcolepsy and heart problems.
'Molecular Movie' Opens Door to New Cancer Treatments
An international team of scientists led by the University of Liverpool has produced a 'structural movie' revealing the step-by-step creation of an important naturally occurring chemical in the body that plays a role in some cancers.
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
Preparing for Potential Zika Outbreaks
Experts at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) are developing tools to monitor the spread of the Zika virus and are conducting research to gather more solid data to better assess the risks associated with the infection.
What do Banana Peels and Human Skin Have in Common?
Human skin and banana peels have something in common: they produce the same enzyme when attacked. By studying fruit, researchers have come up with an accurate method for diagnosing the stages of this form of skin cancer.
Biomarker for Recurring HPV-Linked Oropharyngeal Cancers
A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!